Crossmark

Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer

Crossref DOI link: https://doi.org/10.1038/bjc.2015.114

Published Online: 2015-03-31

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sun, S

Liang, X

Zhang, X

Liu, T

Shi, Q

Song, Y

Jiang, Y

Wu, H

Jiang, Y

Lu, X

Pang, D
License Information

Text and Data Mining valid from 2015-03-31
More Information

Article History

Revised: 16 February 2015

Accepted: 3 March 2015

First Online: 31 March 2015

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below